Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they received 10 weeks ago that laid them off. Damage to their projects may ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

Trump's budget plan would bar clinics that provide abortions — which tend to be testing sites for HIV — from accepting ...

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more t… ...